Skip to main content

FDA Updates

FDA Approves First Hormonal-Based Therapy for Men with Advanced or Metastatic Breast Cancer

Proposed Landmark Policy Changes to Modernize Mammography and Raise Breast Density Awareness

FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer

FDA Approves Tecentriq plus Abraxane—First Immunotherapy for PD-L1– Positive Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer

March 08, 2019 – FDA Approvals, News & Updates

FDA Approves Pembrolizumab for Treatment of Advanced Melanoma

FDA Approves Split-Dosing Regimen for Daratumumab in Patients with Multiple Myeloma

February 8, 2019 - FDA Approvals, News & Updates

February 1, 2019 - FDA Approvals, News & Updates

Government Shutdown Impacts FDA Drug Approvals

19
20
21
22
23
24
25

Page 22 of 33
Results 211 - 220 of 330